V-Flow Medical

V-Flow Medical was dedicated to addressing chronic pelvic pain, a condition affecting over 15 million women in the United States and costing over $39 billion annually. The company developed a suite of products designed to target the underlying causes of this debilitating condition, with the goal of enabling women to avoid opioid use and regain a pain-free life. The V-Flow Medical team possessed a strong track record of scaling medical device startups across various clinical areas, achieving a combined exit value exceeding $4 billion. They established a comprehensive intellectual property portfolio encompassing both device design and application methods, with competitive landscaping indicating no directly competing IP for their specific use case. Beta prototypes were tested, and animal models were initiated in preparation for planned human trials. The company also engaged with NIH program advisors and were encouraged to pursue a Phase 1 grant to further their research into non-drug treatments for chronic pelvic pain.